国际外科学杂志
國際外科學雜誌
국제외과학잡지
INTERNATIONAL JOURNAL OF SURGERY
2012年
12期
846-848
,共3页
肝炎病毒,乙型%癌,肝细胞%抗病毒治疗%风险评估
肝炎病毒,乙型%癌,肝細胞%抗病毒治療%風險評估
간염병독,을형%암,간세포%항병독치료%풍험평고
Hepatitis B virus%Carcinoma,hepatocellular%Antiviral therapy%Risk estimation
肝细胞癌在全世界的发病率逐年增高,已经成为导致癌症相关死亡的主要疾病之一.多年来研究发现,乙型肝炎病毒的慢性感染是导致肝细胞癌发病的重要原因,针对乙肝的抗病毒治疗可明显降低肝细胞癌的发病率及术后的肿瘤复发.对乙型肝炎患者做出适当的相关风险评估,给予高危患者及时有效的医疗干预,对于预防肝细胞癌的发生,延缓其发展有重要作用.
肝細胞癌在全世界的髮病率逐年增高,已經成為導緻癌癥相關死亡的主要疾病之一.多年來研究髮現,乙型肝炎病毒的慢性感染是導緻肝細胞癌髮病的重要原因,針對乙肝的抗病毒治療可明顯降低肝細胞癌的髮病率及術後的腫瘤複髮.對乙型肝炎患者做齣適噹的相關風險評估,給予高危患者及時有效的醫療榦預,對于預防肝細胞癌的髮生,延緩其髮展有重要作用.
간세포암재전세계적발병솔축년증고,이경성위도치암증상관사망적주요질병지일.다년래연구발현,을형간염병독적만성감염시도치간세포암발병적중요원인,침대을간적항병독치료가명현강저간세포암적발병솔급술후적종류복발.대을형간염환자주출괄당적상관풍험평고,급여고위환자급시유효적의료간예,대우예방간세포암적발생,연완기발전유중요작용.
The incidence of hepatocellular carcinoma is increasing year by year all over the world.Hepatoma has become one of the main causes of cancer-related death.For many years,studies found the chronic hepatitis B virus infection is the leading cause of hepatocellular carcinoma,and antiviral therapy for hepatitis B virus could obviously reduce the incidence of hepatoma and prevent recurrence after hepatectomy.Making appropriate risk estimation in patients with chronic hepatitis B and providing patients with high risk the effective medical intervention can help to prevent the occurrence and delay the development of hepatocellular carcinoma.
